Mary E. Ritchey, PhD, FISPE

Chief Scientific Officer
Med Tech Epi

Poster(s):

• (B-294) Comparative risk of hip fracture associated with initiation of Z-drugs among patients with and without osteoporosis
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (C-233) Emulating a Clinical Trial to Assess the Fitness of Real-World Data for Evaluating the Cardiovascular Safety of Fixed-Dose Combination Naltrexone/Bupropion in the United States
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (A-211) Real-World Data for Evidence Generation Supporting FDA Approvals for Labeling Extension of Drugs and Biologics
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (B-282) Risk of upper gastrointestinal (GI) bleeding associated with initiation of oral systemic corticosteroids among patients with and without any pre-existing GI bleed
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET